ro7020531
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 12, 2016 (NCT02956850)
Timeline
Indications
Mechanism of action
- Toll-like receptor 7AGONIST
TLR7 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ro7020531
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04225715 | Phase 2 | Apr 28, 2020 | Roche |
| NCT03530917 | Phase 1 | May 15, 2018 | Roche |
| NCT02956850 | Phase 1 | Dec 12, 2016 | Roche |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 3 | 3 | 2 | 2016 |
1 organizations
Page 1 / 1